Piramal Pharma Limited had a revenue of 20.44B in the quarter ending Sep 30, 2025, with 5.69%. This bring the company's revenue in the last twelve months to 88.46B, Increased -2.19%. In the fiscal year ending Mar 31, 2025, Piramal Pharma Limited had annual revenue of 90.61B with 11.78% growth.